Form 4: Oscar Health CEO Mark Bertolini Vests 955,555 Restricted Stock Units
SEC Form 4 Filing
Oscar Health's CEO, Mark Bertolini, vested 955,555 restricted stock units on April 3, 2024, which convert to Class A common stock.
Summary
- On April 3, 2024, Mark T. Bertolini, CEO of Oscar Health, Inc., vested 955,555 restricted stock units.
- These restricted stock units convert into 955,555 shares of Class A common stock.
- The vesting occurred in accordance with a pre-existing arrangement.
- Following the transaction, Mr. Bertolini directly owns 1,911,111 derivative securities.
- The restricted stock units vest in three equal annual installments beginning on April 3, 2024, contingent upon continued employment or service.
Sentiment
Score: 7
Explanation: The document reflects a routine executive compensation event, which is generally viewed neutrally to positively as it incentivizes management. There are no indications of financial distress or negative performance.
Positives
- The vesting of restricted stock units aligns the CEO's interests with those of the shareholders.
- The vesting schedule encourages continued service and commitment from the CEO.
Future Outlook
The restricted stock units will continue to vest in three equal annual installments, contingent upon the Reporting Person's continued employment or service.
Industry Context
Executive compensation packages often include restricted stock units to incentivize long-term performance and align executive interests with shareholder value. The vesting schedule is a common practice to ensure continued commitment.
Comparison to Industry Standards
- Granting restricted stock units is a common practice among publicly traded companies to incentivize executives.
- Vesting schedules, such as the three-year annual installment plan used by Oscar Health, are standard in the industry to promote long-term commitment.
- Comparable companies like Teladoc Health and Humana also utilize equity-based compensation for their executives.
Stakeholder Impact
- The vesting of restricted stock units aligns the CEO's interests with those of the shareholders, potentially leading to increased shareholder value.
- Continued service of the CEO is ensured through the vesting schedule, which benefits employees and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| March 29, 2023 | Date of Power of Attorney execution. |
| April 3, 2024 | Date of transaction: vesting of restricted stock units and first vesting installment. |
| April 5, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.